Lloyd Duplechan joins Ethics Talk to discuss health organizations’ responsibilities to protect employees and community members from antimicrobial resistance.
Research on emergency room patients with life-threatening illness, conducted under the FDA-approved Exception From Informed Consent (EFIC) policy, does not further reduce the autonomy of such patients and offers potential benefit to those patients as well as others.
Ownership rights to tissue donated for research end when the tissue leaves the body, as does all claim to benefit from commercial cell lines or other products derived from the tissue.
I’m sorry laws, enacted in the majority of states, encourage physicians to apologize for unexpected outcomes and errors by making such apologies inadmissible in civil court to prove liability.
Maureen Kelley, PhD discusses the dual-use dilemma in infectious disease research. The same scientific information or products intended for good can also fall into the wrong hands and be used to threaten a population in an act of bioterrorism.
In “Ethics of International Research: What Does Responsiveness Mean?” Christine Grady explains how developing countries are vulnerable to exploitation by researchers and explores what “responsiveness” to the needs of those populations might entail.
Three reports considered by the Council on Ethical and Judicial Affairs are described, along with the process for revising the AMA's Code of Medical Ethics and trivia about contraceptive use.